Sign in Subscribe
Cancer research

Liquid-Liquid Phase Separation Linked to Liver Cancer Progression

Strategic Insights

— 1 min read

Researchers from the First Affiliated Hospital of Guangzhou Medical University have investigated the relationship between liquid-liquid phase separation (LLPS) and hepatocellular carcinoma (HCC), a type of liver cancer. Their study aimed to identify LLPS-related molecular features and develop a prognostic signature for HCC. The team analyzed single-cell RNA sequencing and bulk RNA sequencing data to identify LLPS-related genes and constructed a risk model for predicting patient outcomes. Their findings suggest that high-LLPS hepatocytes are associated with malignant differentiation and that knockdown of specific genes can inhibit HCC cell migration and invasion.

Key Takeaways:

  • The study identified 10 LLPS-related genes (LLPSRGs) associated with HCC prognosis, including LGALS3, G6PD, and others.
  • The LLPS score was associated with malignant differentiation of hepatocytes and predicted patient outcomes.
  • Knockdown of LGALS3 inhibited HCC cell migration and invasion, suggesting potential therapeutic targets.
  • The study developed a predictive nomogram for assessing patient risk based on LLPS score and clinicopathologic features.
  • The findings provide new insights into HCC research and offer potential therapeutic targets for the treatment of liver cancer.

The research published in Scientific Reports highlights the potential of LLPS-related molecular characteristics in predicting patient outcomes for HCC. The study's findings suggest that a deeper understanding of LLPS-related mechanisms may lead to the development of novel therapeutic strategies for the treatment of liver cancer.

Statistics:

  • 14 distinct cell clusters were identified in the study, with malignant hepatocytes exhibiting the highest LLPS score.
  • High-LLPS hepatocytes showed elevated expression of EGFR-ERGF, EGFR-AREG, MIF-CD44, and MIF-CXCR4 interactions.
  • Ten LLPSRGs were identified, including LGALS3, and potential therapeutic agents were predicted: Olitigaltin and Lactose for LGALS3, and Sitamaquine, Phenazopyridine, Sulfanilamide, Pamaquine, Sodium ascorbate, and Co-trimoxazole for G6PD.

Sources:

  • Integration of single-cell and bulk RNA sequencing data to identify liquid-liquid phase separation-related prognostic biomarkers in hepatocellular carcinoma. Scientific Reports, 2025;15(1):36805.
  • Nature Portfolio, Heidelberger Platz 3, Berlin, 14197, Germany.
  • Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Xi Road, Yuexiu District, Guangzhou, 510120, People's Republic of China.

Read more